Medical Condition News

RSS

New analytical method can improve detection of dimethyl fumarate in leather and footwear

Researchers at Igualada School of Engineering, a school associated with the Universitat Politècnica de Catalunya, have developed a new analytical method that improves detection of dimethyl fumarate in leather and footwear.

24 May 2011

Variant of obesity gene may increase breast cancer risk

New research aimed to better identify the genetic factors that lead to breast cancer has uncovered a link between the fat mass and obesity associated gene and a higher incidence of breast cancer.

24 May 2011

Mount Sinai researchers identify protein signaling hyperactivity in human sarcoma cells

Researchers from Mount Sinai School of Medicine have discovered a protein signaling pathway that becomes hyperactivated in human sarcoma cells, suggesting that medications to inhibit this pathway may be effective in the treatment of human sarcomas. The research is published in the current issue of the journal Cancer Cell.

24 May 2011

'Survival protein' protects brain against effects of stroke

Johns Hopkins scientists say that a newly discovered "survival protein" protects the brain against the effects of stroke in rodent brain tissue by interfering with a particular kind of cell death that's also implicated in complications from diabetes and heart attack.

24 May 2011

NIH awards $3.03 million grant to UTMB researcher to continue groundbreaking aging study

Rebeca Wong, one of the nation's foremost experts on aging, has been awarded $3.03 million by the National Institute on Aging of the National Institutes of Health to continue a groundbreaking study in Mexico. Wong will use the grant for a longitudinal aging study she and collaborators started in 2001.

24 May 2011

African-Americans with multiple sclerosis have lower vitamin D levels

African-Americans who have multiple sclerosis have lower vitamin D levels than African-Americans who don't have the disease, according to a study published in the May 24, 2011, print issue of Neurology, the medical journal of the American Academy of Neurology.

24 May 2011

Aptus EndoStapling System receives CE Mark approval

Aptus Endosystems, Inc., a medical device company developing advanced technology for endovascular aneurysm repair (EVAR), announced CE Mark approval for the Aptus EndoStapling System. The innovative helical staple technology enables independent endograft fixation, and is designed to mimic the hand suturing performed during open surgical repair of abdominal aortic aneurysms.

From Medtronic 24 May 2011

Journal of Clinical Oncology publishes Exelixis' cabozantinib phase 1 trial results in lymphoma

Exelixis, Inc. today announced the results of the phase 1 clinical trial of cabozantinib in patients with advanced solid tumors or lymphoma have been published in the current issue of the Journal of Clinical Oncology.

24 May 2011

Johns Hopkins bioethicists urge disaster preparedness for mentally impaired

Johns Hopkins bioethicists say disaster-response planning has generally overlooked the special needs of people who suffer from pre-existing and serious mental conditions. Survivors already diagnosed with schizophrenia, dementia, addictions and bipolar disorder are vulnerable long before a disaster strikes, they point out.

23 May 2011

Expert review of respiratory medicine on pulmonary hypertension

Pulmonary hypertension (PH) is a rare, often incurable lung disorder that affects individuals of all ages, races and ethnic backgrounds. In the recent 4th World Conference on Pulmonary Hypertension held by the WHO, PH was classified into five groups based on its causes, highlighting both the magnitude of conditions associated with PH and how little we know of the etiology in many cases.

23 May 2011

Substantial portion of patients with headaches improve without treatment

Headache is a very common complaint, with over 90% of all persons experiencing a headache at some time in their lives. Headaches commonly are tension-type (TTH) or migraine. They have high socioeconomic impact and can disturb most daily activities. Treatments range from pharmacologic to behavioral interventions.

23 May 2011

Positive results from Relypsa RLY5016 Phase 2 trial to be presented at American Society of Hypertension meeting

Relypsa, Inc. today announced the presentation of positive results from a Phase 2 clinical trial of the company's lead compound, RLY5016, a non-absorbed oral potassium binder being developed as a treatment for hyperkalemia (elevated serum potassium levels).

23 May 2011

Elixir DESyne Drug Eluting Coronary Stent System granted CE Mark approval

Elixir Medical Corporation, a developer of product platforms combining state-of-the-art medical devices with advanced pharmaceuticals, announced that it has received CE Mark for its DESyne Drug Eluting Coronary Stent System for the treatment of coronary artery disease.

23 May 2011

Lifestyle modifications help control blood pressure levels: More evidence

Evidence continues to build that lifestyle modifications help control blood pressure (BP) levels. Data evaluating the consumption of coffee and alcohol and the impact of low fitness levels will be presented at the American Society of Hypertension, Inc.'s 26th Annual Scientific Meeting and Exposition (ASH 2011) and will be featured in the May 22 ASH press briefing.

23 May 2011

OptiNose wins 200,000 NOK award for novel bi-directional nasal drug delivery technology

OptiNose Inc. announced that the Company has recently won the Oslo regional finals of the DnB NOR Innovation Award for its novel, bi-directional nasal drug delivery technology.

23 May 2011

Sangamo announces presentations of ZFP Therapeutics data at ASGCT 2011

Sangamo BioSciences, Inc. announced today that data from clinical, preclinical and research-stage programs focused on the development of zinc finger DNA-binding protein Therapeutics were described in twenty presentations given by Sangamo scientists and collaborators at the 14th Annual Meeting of the American Society of Gene and Cell Therapy.

23 May 2011

Nano-complex pre-meal dietary supplement can reduce fat and sugar absorption in the body

A little bitter with a little sweet, in the form of a nano-complex dietary supplement taken before meals, can result in a substantial reduction of fat and sugar absorption in the body, Hebrew University of Jerusalem and Harvard University researchers have found.

23 May 2011

Mylan introduces Divalproex Sodium Capsules for treatment of seizures

Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has launched Divalproex Sodium Capsules USP, 125 mg, the generic version of Abbott's Depakote® Sprinkle Capsules, a treatment for certain types of seizures.

23 May 2011

Micromet's blinatumomab data to be presented at two upcoming medical meetings

Micromet, Inc., a biopharmaceutical company focused on the development and commercialization of next-generation antibodies for the treatment of cancer, today announced that data on its lead product candidate blinatumomab will be reported at two upcoming medical meetings.

23 May 2011

Millennium Laboratories founder to be honored as 2011 Ernst & Young Entrepreneur for pain care

Millennium Laboratories, a leading provider of medication monitoring services to physicians and staff treating chronic pain, announced today that James Slattery, CEO and founder, is a regional finalist for the Ernst & Young Entrepreneur of the Year 2011 San Diego region.

23 May 2011

Medical Condition News

New analytical method can improve detection of dimethyl fumarate in leather and footwear

Variant of obesity gene may increase breast cancer risk

Mount Sinai researchers identify protein signaling hyperactivity in human sarcoma cells

'Survival protein' protects brain against effects of stroke

NIH awards $3.03 million grant to UTMB researcher to continue groundbreaking aging study

African-Americans with multiple sclerosis have lower vitamin D levels

Aptus EndoStapling System receives CE Mark approval

Journal of Clinical Oncology publishes Exelixis' cabozantinib phase 1 trial results in lymphoma

Johns Hopkins bioethicists urge disaster preparedness for mentally impaired

Expert review of respiratory medicine on pulmonary hypertension

Substantial portion of patients with headaches improve without treatment

Positive results from Relypsa RLY5016 Phase 2 trial to be presented at American Society of Hypertension meeting

Elixir DESyne Drug Eluting Coronary Stent System granted CE Mark approval

Lifestyle modifications help control blood pressure levels: More evidence

OptiNose wins 200,000 NOK award for novel bi-directional nasal drug delivery technology

Sangamo announces presentations of ZFP Therapeutics data at ASGCT 2011

Nano-complex pre-meal dietary supplement can reduce fat and sugar absorption in the body

Mylan introduces Divalproex Sodium Capsules for treatment of seizures

Micromet's blinatumomab data to be presented at two upcoming medical meetings

Millennium Laboratories founder to be honored as 2011 Ernst & Young Entrepreneur for pain care

CoppaFeel!: Breast Cancer Doesn’t Discriminate, So Why Should Awareness?

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Latest News